Native Antigen

Native & recombinant viral & bacterial #antigens, #antibodies, immunoassays & services for #vaccine & #diagnostic development in #infectiousdisease

[Native Antigen @nativeantigen]

The WHO last week announced its #vaccine recommendations for the 2022/2023 Northern Hemisphere #flu season.

The Native Antigen Company offers HA and NA #antigens for many of these viruses, with the remainder anticipated to be available in early April.

https://t.co/LXuVZpCzrB

[Native Antigen @nativeantigen]

In this editorial for @biocompare, we comment on the role of reagents in assessing the efficacy of vaccines, and their broad application in supporting the development of novel technologies.

#Vaccines #mRNA #Pharma #Biotech #Antibodies #Antigen #Serology

https://t.co/HP9ndBLQMH

[European Biopharmaceutical Review @EBRmagazine]

James Shore at @nativeantigen explores the challenges of flaviviruses and the urgent need for more accurate data.

Read the full article (and many more) 👇

https://t.co/NFAmbOh4DE

[Native Antigen @nativeantigen]

To support #vaccine development for the upcoming 2022 Southern Hemisphere flu season, The Native Antigen Company now offers formulation-specific HA and NA #antigens.

#flu #influenza #reagents #IVD #Vaccines

https://t.co/LXuVZpD7h9

[Native Antigen @nativeantigen]

The Native Antigen Company now offers a new range of services for virological research and the development of diagnostics, therapeutics, and vaccines.

To find out more, click the link below or get in touch at: [email protected]

https://t.co/pjZHLb85sn

[Native Antigen @nativeantigen]

In European Biopharmaceutical Review's latest issue, we discuss the emergence of the flaviviruses and challenges in developing effective serological #diagnostics for their detection.

To read the full article, see pages 32 - 35.

https://t.co/TDxYpFDVUa

[Native Antigen @nativeantigen]

The Native Antigen Company offers new #humanized antibodies to SARS-CoV-2, that show differential affinities and neutralising ability to variants.

For more information on these products, click the link below or get in touch at: [email protected]

https://t.co/uaGknviK3W

[Native Antigen @nativeantigen]

In BioPharm International's latest industry Q&A on #COVID19 vaccines, we explain the role of variant-specific reagents in vaccine testing and how they can be developed at speed.

https://t.co/9N1ChH2o8N

[BioTechniques @MyBioTechniques]

Discover the story of the production of the first commercially available SARS-CoV-2 spike proteins and the fortuitous circumstances that led to their creation in this interview feature with James Shore of @nativeantigen.
https://t.co/9rHSFQlY6g

[Native Antigen @nativeantigen]

To support #norovirus research and development, The Native Antigen Company offers norovirus-like particles for six new #genotypes, four of which are unique.

For more information, click the link below or get in touch at: [email protected]

https://t.co/xmEpdo6Sm7

[Native Antigen @nativeantigen]

A structural analysis of the #SARSCoV2 #Omicron Spike trimer reveals that many of its mutations are present at the protein surface, where they confer a near 10-fold increase in #ACE2 binding affinity while decreasing affinity to many antibodies.

https://t.co/iih6uQcPho

[Native Antigen @nativeantigen]

The Native Antigen Company offers a growing range of SARS-CoV-2 #Omicron (B.1.1.529) antigens, now including whole Spike, S1 and RBD.

https://t.co/25tyuI9lp8

For more information on these products, click the link below or get in touch at:

[email protected]

[Native Antigen @nativeantigen]

LGC Clinical Diagnostics will be attending MEDLAB Middle East 24-27 January. Visit us at booth Z6. D48. To learn more, or to schedule time with one of our onsite representatives, click here: https://t.co/E9XbCMXSxW

[Native Antigen @nativeantigen]

Take a look at our open positions in Marketing, Sales, Finance, New Product Development, and Operations! Apply now: https://t.co/7vdSFYgVhY

[Native Antigen @nativeantigen]

The Native Antigen Company is now taking orders for SARS-CoV-2 #Omicron (B.1.1.529) whole Spike, S1 and RBD antigens.

https://t.co/25tyuI9lp8

For more information on these products, click the link below or get in touch at: [email protected]

[Native Antigen @nativeantigen]

Need a refresher on COVID-19 serology?

In this July article written for @CLPmag, Dr Andy Lane provides an overview of the role of #serology in tracking #COVID19 mutations.

https://t.co/ze8DO62cKQ

#Vaccines #Diagnostics #Omicron #COVID

[Native Antigen @nativeantigen]

We're thrilled to announce that our SARS-CoV-2 Neutralization Assay Development Kits have been recognised by @TheScientistLLC as a Top 10 Innovation of 2021.

https://t.co/Kaot9huy6V

[Native Antigen @nativeantigen]

To support #vaccine and diagnostic R&D, we are developing #Spike and #RBD antigens for the emergent #Omicron variant.

If you have any questions or would like to speak with a member of our R&D team, get in touch at: [email protected]

https://t.co/eWUDsuQmmD

[Native Antigen @nativeantigen]

A new variant, B.1.1.529, likely to be designated "Nu", has been detected in #SouthAfrica, Hong Kong and Botswana.

#B11519 harbors more than 30 #Spike mutations. However, its #transmissibility and ability to evade #immunity are yet unknown.

https://t.co/d3HUbKFwQi

[Native Antigen @nativeantigen]

In this article for the IAHJ Journal, we explore #OneHealth approaches to integrating human-#veterinary diagnosis at the point-of-care:

https://t.co/KATnJLqcbi